Halozyme Therapeutics competitors, on the record

Who Halozyme Therapeutics names

In its own words

1. Alteogen Inc.

   Word for word“For example, Alteogen Inc. has developed ALT‑B4, a modified human hyaluronidase that has been licensed for use in SC formulations.” 10-K for 2025

2. Amphastar Pharmaceuticals, Inc.

   Word for word“The competitors for Hylenex recombinant include Amphastar Pharmaceuticals, Inc.’s product, Amphadase ® , a bovine (bull) hyaluronidase.” 10-K for 2025

3. Endo, Pfizer

   Word for word“Other forms of testosterone replacement therapy include injectables such as Endo’s Aveed ® and Pfizer’s Depo®-Testosterone, surgically implanted Testopel ® pellets by Endo and intranasal Natesto ® .” 10-K for 2025

4. Lilly, Teva, Viatris

   Word for word“Our competitors include established specialty pharmaceutical companies, major brand name and generic manufacturers of pharmaceuticals such as Teva, Viatris, Lilly and Endo, as well as a wide range of medical device companies that sell a single or limited number of competitive products or participate in only a specific market segment.” 10-K for 2025

5. Marius Pharmaceuticals, Inc., Tolmar Pharmaceuticals, Inc., Verity Pharmaceuticals Inc.

   Word for word“JATENZO ® by Tolmar Pharmaceuticals, Inc., TLANDO ® by Verity Pharmaceuticals Inc. and Kyzatrex by Marius Pharmaceuticals, Inc. all represent oral formulations of testosterone.” 10-K for 2025

6. Owen Mumford Ltd., Scandinavian Health Ltd., West Pharmaceutical, Ypsomed AG

   Word for word“Our competitors also include third party contract medical device design and development companies such as Scandinavian Health Ltd., Ypsomed AG, West Pharmaceutical and Owen Mumford Ltd.” 10-K for 2025

Read from Halozyme Therapeutics’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-17. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.